Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|82|5|739-746

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.82, Iss.5, 2015-05, pp. : 739-746

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of external beam radiation therapy in non-functioning pituitary adenomas: a case–control, nested in a cohort study

By  

Journal of Radiotherapy in Practice, Vol. 13, Iss. 1, 2013-05 ,pp. : 87-92

Cambridge University Press

Access to resources Recommend Favorite

Clinical outcomes in patients with nonfunctioning pituitary adenomas managed conservatively

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 861-865

John Wiley & Sons Inc

Access to resources Recommend Favorite

Correlation between SPARC (Osteonectin) expression with immunophenotypical and invasion characteristics of pituitary adenomas

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 3, 2015-03 ,pp. : 199-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Long‐Term Alcohol Drinking on the Dopamine D2 Receptor: Gene Expression and Heteroreceptor Complexes in the Striatum in Rats

By  

ALCOHOLISM (ELECTRONIC), Vol. 42, Iss. 2, 2018-02 ,pp. : 338-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gamma Knife Radiosurgery for Pituitary Adenomas

By  

Stereotactic and Functional Neurosurgery, Vol. 72, Iss. 1, 1999-12 ,pp. : 111-118

Karger

Access to resources Recommend Favorite